These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 39284549)

  • 1. DHRS2-induced SPHK1 downregulation contributes to the cell growth inhibition by Trichothecin in colorectal carcinoma.
    Liu H; Li X; Liu W; Zhang C; Zhang S; Zhou X; Bode AM; Luo X
    Biochim Biophys Acta Mol Cell Res; 2024 Dec; 1871(8):119846. PubMed ID: 39284549
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DHRS2 mediates cell growth inhibition induced by Trichothecin in nasopharyngeal carcinoma.
    Luo X; Li N; Zhao X; Liao C; Ye R; Cheng C; Xu Z; Quan J; Liu J; Cao Y
    J Exp Clin Cancer Res; 2019 Jul; 38(1):300. PubMed ID: 31291971
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DHRS2 inhibits cell growth and metastasis in ovarian cancer by downregulation of CHKα to disrupt choline metabolism.
    Li Z; Tan Y; Li X; Quan J; Bode AM; Cao Y; Luo X
    Cell Death Dis; 2022 Oct; 13(10):845. PubMed ID: 36192391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SphK1 promotes tumor cell migration and invasion in colorectal cancer.
    Long J; Xie Y; Yin J; Lu W; Fang S
    Tumour Biol; 2016 May; 37(5):6831-6. PubMed ID: 26662312
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sphingosine kinase 1 overexpression contributes to cetuximab resistance in human colorectal cancer models.
    Rosa R; Marciano R; Malapelle U; Formisano L; Nappi L; D'Amato C; D'Amato V; Damiano V; Marfè G; Del Vecchio S; Zannetti A; Greco A; De Stefano A; Carlomagno C; Veneziani BM; Troncone G; De Placido S; Bianco R
    Clin Cancer Res; 2013 Jan; 19(1):138-47. PubMed ID: 23166225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sphingosine Kinase 1 and Sphingosine-1-Phosphate Signaling in Colorectal Cancer.
    Bao Y; Guo Y; Zhang C; Fan F; Yang W
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 28991193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down regulation of lncRNA MEG3 promotes colorectal adenocarcinoma cell proliferation and inhibits the apoptosis by up-regulating TGF-β1 and its downstream sphingosine kinase 1.
    Dong X; Wang J; Li T; Xu YP; Li SY
    Eur Rev Med Pharmacol Sci; 2018 Dec; 22(23):8265-8272. PubMed ID: 30556866
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intracellular role for sphingosine kinase 1 in intestinal adenoma cell proliferation.
    Kohno M; Momoi M; Oo ML; Paik JH; Lee YM; Venkataraman K; Ai Y; Ristimaki AP; Fyrst H; Sano H; Rosenberg D; Saba JD; Proia RL; Hla T
    Mol Cell Biol; 2006 Oct; 26(19):7211-23. PubMed ID: 16980623
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression profiling of genes regulated by sphingosine kinase1 signaling in a murine model of hyperoxia induced neonatal bronchopulmonary dysplasia.
    Natarajan V; Ha AW; Dong Y; Reddy NM; Ebenezer DL; Kanteti P; Reddy SP; Usha Raj J; Lei Z; Maienschein-Cline M; Arbieva Z; Harijith A
    BMC Genomics; 2017 Aug; 18(1):664. PubMed ID: 28851267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ginsenoside compound K inhibits angiogenesis via regulation of sphingosine kinase-1 in human umbilical vein endothelial cells.
    Shin KO; Seo CH; Cho HH; Oh S; Hong SP; Yoo HS; Hong JT; Oh KW; Lee YM
    Arch Pharm Res; 2014; 37(9):1183-92. PubMed ID: 24687256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the dehydrogenase-reductase DHRS2 and its involvement in histone deacetylase inhibition in urological malignancies.
    Müller MR; Burmeister A; Skowron MA; Stephan A; Söhngen C; Wollnitzke P; Petzsch P; Alves Avelar LA; Kurz T; Köhrer K; Levkau B; Nettersheim D
    Exp Cell Res; 2024 Jun; 439(1):114055. PubMed ID: 38704080
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Trichothecin inhibits invasion and metastasis of colon carcinoma associating with SCD-1-mediated metabolite alteration.
    Liao C; Li M; Li X; Li N; Zhao X; Wang X; Song Y; Quan J; Cheng C; Liu J; Bode AM; Cao Y; Luo X
    Biochim Biophys Acta Mol Cell Biol Lipids; 2020 Feb; 1865(2):158540. PubMed ID: 31678511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Concomitant targeting of FLT3 and SPHK1 exerts synergistic cytotoxicity in FLT3-ITD
    Jiang L; Zhao Y; Liu F; Huang Y; Zhang Y; Yuan B; Cheng J; Yan P; Ni J; Jiang Y; Wu Q; Jiang X
    Cell Commun Signal; 2024 Aug; 22(1):391. PubMed ID: 39113090
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cross-talk between LPA1 and epidermal growth factor receptors mediates up-regulation of sphingosine kinase 1 to promote gastric cancer cell motility and invasion.
    Shida D; Fang X; Kordula T; Takabe K; Lépine S; Alvarez SE; Milstien S; Spiegel S
    Cancer Res; 2008 Aug; 68(16):6569-77. PubMed ID: 18701480
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SphK1/S1P Mediates PDGF-Induced Pulmonary Arterial Smooth Muscle Cell Proliferation via miR-21/BMPRII/Id1 Signaling Pathway.
    Li F; Wang J; Zhu Y; Liu L; Feng W; Shi W; Wang Q; Zhang Q; Chai L; Li M
    Cell Physiol Biochem; 2018; 51(1):487-500. PubMed ID: 30453304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Sphingosine kinase 1 enhances colon cancer cell proliferation and invasion by upregulating the production of MMP-2/9 and uPA via MAPK pathways.
    Liu SQ; Huang JA; Qin MB; Su YJ; Lai MY; Jiang HX; Tang GD
    Int J Colorectal Dis; 2012 Dec; 27(12):1569-78. PubMed ID: 22684547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SPHK1 Is a Novel Target of Metformin in Ovarian Cancer.
    Hart PC; Chiyoda T; Liu X; Weigert M; Curtis M; Chiang CY; Loth R; Lastra R; McGregor SM; Locasale JW; Lengyel E; Romero IL
    Mol Cancer Res; 2019 Apr; 17(4):870-881. PubMed ID: 30655321
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of cellular sphingosine-1-phosphate by sphingosine kinase 1 and sphingosine-1-phopshate lyase determines chemotherapy resistance in gastroesophageal cancer.
    Matula K; Collie-Duguid E; Murray G; Parikh K; Grabsch H; Tan P; Lalwani S; Garau R; Ong Y; Bain G; Smith AD; Urquhart G; Bielawski J; Finnegan M; Petty R
    BMC Cancer; 2015 Oct; 15():762. PubMed ID: 26493335
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-495-3p regulates sphingolipid metabolic reprogramming to induce Sphk1/ceramide mediated mitophagy and apoptosis in NSCLC.
    Arora S; Singh P; Tabassum G; Dohare R; Syed MA
    Free Radic Biol Med; 2022 Aug; 189():71-84. PubMed ID: 35853537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The sphingosine kinase 1 and S1P1 axis specifically counteracts LPS-induced IL-12p70 production in immune cells of the spleen.
    Schröder M; Richter C; Juan MH; Maltusch K; Giegold O; Quintini G; Pfeilschifter JM; Huwiler A; Radeke HH
    Mol Immunol; 2011 May; 48(9-10):1139-48. PubMed ID: 21435724
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.